Portal systemic encephalopathy. 1984

J Newell

Portal systemic encephalopathy is a neuropsychiatric disorder that occurs secondary to chronic liver disease. It is a chronic and disabling disorder that must be treated concurrently with liver disease. In chronic liver disease, the regenerative capacity of the liver to produce new cells is eventually hampered and scar tissue develops. Scarring reduces blood flow through the liver. The vein most affected is the portal vein which contributes 75 percent of the blood to the liver as it evolves from tributaries off the abdominal organs. To eliminate the high pressure in the portal vein caused by the reduced blood flow, the portal vein develops collateral vessels that bypass the liver and drain directly into the inferior vena cava. When blood is not cleared, or when hepatic functioning fails, toxins accumulate in the circulation and affect the central nervous system. The neuropsychiatric manifestations that occur represent the symptoms seen in portal systemic encephalopathy. With renewed understanding of the disease and its neuropsychiatric manifestations, both clinicians and patients are able to minimize its untoward effects. This article reviews the pathogenesis, stages, diagnosis and treatment of the disease and aims at giving nurse practitioners a thorough review so they can better teach patients how to help themselves.

UI MeSH Term Description Entries
D007792 Lactulose A synthetic disaccharide used in the treatment of constipation and hepatic encephalopathy. It has also been used in the diagnosis of gastrointestinal disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p887) Amivalex,Duphalac,Normase
D004044 Dietary Proteins Proteins obtained from foods. They are the main source of the ESSENTIAL AMINO ACIDS. Proteins, Dietary,Dietary Protein,Protein, Dietary
D006501 Hepatic Encephalopathy A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5) Encephalopathy, Hepatic,Portosystemic Encephalopathy,Encephalopathy, Hepatocerebral,Encephalopathy, Portal-Systemic,Encephalopathy, Portosystemic,Fulminant Hepatic Failure with Cerebral Edema,Hepatic Coma,Hepatic Stupor,Hepatocerebral Encephalopathy,Portal-Systemic Encephalopathy,Coma, Hepatic,Comas, Hepatic,Encephalopathies, Hepatic,Encephalopathies, Hepatocerebral,Encephalopathies, Portal-Systemic,Encephalopathies, Portosystemic,Encephalopathy, Portal Systemic,Hepatic Comas,Hepatic Encephalopathies,Hepatic Stupors,Hepatocerebral Encephalopathies,Portal Systemic Encephalopathy,Portal-Systemic Encephalopathies,Portosystemic Encephalopathies,Stupor, Hepatic,Stupors, Hepatic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

J Newell
May 1997, Clinics in liver disease,
J Newell
January 2000, Ryoikibetsu shokogun shirizu,
J Newell
January 1988, The American journal of gastroenterology,
J Newell
December 1960, Southern medical journal,
J Newell
February 1987, JPMA. The Journal of the Pakistan Medical Association,
J Newell
January 2004, Nihon rinsho. Japanese journal of clinical medicine,
J Newell
February 1995, The Tohoku journal of experimental medicine,
J Newell
August 1998, Internal medicine (Tokyo, Japan),
J Newell
January 2015, Internal medicine (Tokyo, Japan),
J Newell
April 1981, Digestive diseases and sciences,
Copied contents to your clipboard!